Log in to search using one of your social media accounts:

 

Medtronic Puts Insulin Needle Out of Sight, Out of Mind
Medtronic has launched the latest version of its MiniMed Mio insulin infusion set in Canada, Hong Kong and parts of Europe. The MiniMed Mio Advance is an update of the MiniMed Mio, introduced in 2010 and designed to deliver insulin from an insulin pump to the body. The Mio Advance should make changing infusion sets quicker and easier, according to the company. Diabetic patients who use insulin pumps generally change their infusion set every two or three days, selecting different insertion sites to prevent skin breakdown and maximize insulin absorption. Thin plastic tubing included in the set comes in varying lengths to rea...
Source: MDDI - February 23, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Medical Device Business Source Type: news

Novo Nordisk touts promising results from late-stage trial of oral diabetes med
Setting the stage for a battle with rival Eli Lilly (NYSE:LLY), Novo Nordisk (NYSE:NVO) reported data this week from a late-stage trial of its oral formulation of semaglutide, a medication for people with Type II diabetes. The GLP-1 agonist is traditionally administered via injection. Both insulin-makers have approved versions of the injectable semaglutide, but Novo Nordisk is the first to take its oral formulation into large clinical studies. Get the full story at our sister site, Drug Delivery Business News. The post Novo Nordisk touts promising results from late-stage trial of oral diabetes med appea...
Source: Mass Device - February 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Eli Lilly & Co. Novo Nordisk Source Type: news

Valeritas inks distribution deal in Italy for V-Go insulin delivery device
Valeritas (NSDQ:VLRX) has inked an exclusive distribution deal with Movi SpA for the commercialization of its V-Go wearable insulin delivery device in Italy. According to the terms of the deal, Movi will market and sell the V-Go device to diabetes clinics and patients in Italy, while Valeritas will remain responsible for the product’s development, regulatory approval and manufacturing. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas inks distribution deal in Italy for V-Go insulin delivery device appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 22, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Insulet beats the Street with Q4, FY17 sales
Insulet (NSDQ:PODD) reported yesterday that the insulin delivery device-maker topped sales expectations on Wall Street for its fourth quarter and full-year financial results, but missed earnings estimates. The Billerica, Mass.-based company reeled in losses, posting -$6.9 million on sales of $130.5 million for the 3 months ended Dec. 31, for sales growth of 26% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Insulet beats the Street with Q4, FY17 sales appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 22, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Insulet Source Type: news

HealthWatch: Low-Carb Vs. Low-Fat? Probably Doesn ’ t Matter
This study also looked specifically at the subjects’ genetics when it comes to metabolizing fat and carbohydrates, as well as, how their bodies secrete insulin and found that neither of those things seemed to matter when it came to weight loss with the two different diets. Scientists have wondered whether some diets fit a person’s biology better than others and this is an area which will continue to be studied. In the meantime, it’s probably best to find a meal plan that you can stick to. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 21, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Diet Dr. Mallika Marshall Healthy Eating Low Carb Diets Low Fat Source Type: news

Novo Nordisk gets nod from U.S. drug purchaser for new diabetes hope
COPENHAGEN (Reuters) - Insulin maker Novo Nordisk said its Ozempic diabetes drug had been included on a list of medicines approved for patients covered by U.S. private health schemes, setting the stage for a battle with Eli Lilly's Trulicity. (Source: Reuters: Health)
Source: Reuters: Health - February 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
New Infusion Set Offers Simpler, Faster, and More Convenient(1) Insulin Pump Experience DUBLIN - February 21, 2018 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, to... Devices, Drug Delivery, Product Launch Medtronic, MiniMed, Mio Advance, Infusion Set, insulin pump, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 21, 2018 Category: Pharmaceuticals Source Type: news

Medtronic expands insulin pump portfolio with MiniMed Mio infusion set
Medtronic (NYSE:MDT) has launched its MiniMed Mio Advance infusion sets, which are designed for people managing their diabetes with insulin pump therapy. The medtech titan touted its product, which was developed by ConvaTec, as boasting a user-friendly design that allows patients to access hard-to-reach sites, like the lower back. The infusion system has no visible needle and features a built-in insertion device, according to Medtronic. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic expands insulin pump portfolio with MiniMed Mio infusion set appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Medtronic Source Type: news

Tandem Diabetes bids for Health Canada nod
Tandem Diabetes Care (NSDQ:TNDM) has submitted a medical device license application to Health Canada in the hopes of launching its t:slim X2 insulin pump in Canada in the second half of this year. The San Diego, Calif.-based company expects that its device will be able to display both English and French and will include a 24-hour clock. Get the full story at our sister site, Drug Delivery Business News. The post Tandem Diabetes bids for Health Canada nod appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Wall Street Beat tandemdiabetes Source Type: news

Medical News Today: How can I lower my insulin levels?
In this article, we look at nine ways to lower high insulin levels. This can be achieved through diet, lifestyle changes, supplements, and medication. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 21, 2018 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Touchstone Center provides insight into glucagon's role in diabetic heart disease
(UT Southwestern Medical Center) A UT Southwestern study reveals the hormone glucagon's importance to the development of insulin resistance and cardiac dysfunction during Type 2 diabetes, presenting opportunities to develop new therapies for diabetic diseases of the heart muscle. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 21, 2018 Category: International Medicine & Public Health Source Type: news

Researchers develop process producing cell-sized lipid vesicles for cell-cell synaptic therapies
(World Scientific) Novel and robust process to produce functionalized giant unilamellar vesicles (GUVs) on-demand from double emulsions templates results in artificial cells with surface ligand neuroligin-2 (NL-2) to promote insulin secretion in pancreaticβ cells, demonstrating a versatile cell-cell synaptic therapeutic paradigm. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 21, 2018 Category: Biology Source Type: news

Roche ’s Accu-Chek diabetes management app receives its fifth FDA recall
Roche ’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On February 15, the agency issued a Class 2 Device Recall for certain software versions of the app due to a bug that could lead users to self-administer inappropriate doses of insulin. (Source: mobihealthnews)
Source: mobihealthnews - February 20, 2018 Category: Information Technology Source Type: news

DarioHealth launches Dario blood glucose monitor on Amazon
DarioHealth (NSDQ:DRIO) said today it launched its Dario blood glucose monitoring system on the Amazon marketplace, touting that the system has already been sold through the site. The company’s blood glucose monitor, which syncs with Dario’s diabetes management app, connects via a headphone jack to a mobile device, helping diabetes patients monitor their blood glucose throughout the day. The app also records carbohydrate intake, insulin use and physical activity. Read the whole story on our sister site, Drug Delivery Business The post DarioHealth launches Dario blood glucose monitor on Amazo...
Source: Mass Device - February 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diabetes DarioHealth Corp Source Type: news

Pacemakers, other devices at risk for hacking, study says
Medical devices like pacemakers and insulin pumps are at risk for hacking the could have deadly consequences, warns a new report by the American College of Cardiology. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2018 Category: Consumer Health News Source Type: news

It's a Draw! Low-Fat or Low-Carb Diets Equally Good, Finds Study It's a Draw! Low-Fat or Low-Carb Diets Equally Good, Finds Study
A healthy low-fat or healthy low-carb diet did not'fit'a person better, or lead to greater 1-year weight loss if it'matched'their genotype pattern or insulin secretion, contrary to preliminary studies.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 20, 2018 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news

Which Is Better for Weight Loss, a Low-Fat Diet or a Low-Carb Diet?
There’s long been debate over whether low-fat or low-carb diets are better for weight loss. Some dieters swear by plans that eliminate grains, fruits and other carbohydrates, while others defend diets that cut down on red meat, dairy and other fatty foods. So who’s right? Both — and neither, according to new research published in JAMA. In a 600-person, year-long study, the two eating styles helped dieters drop almost exactly the same number of pounds — and there didn’t seem to be much rhyme or reason as to who succeeded on which plan, explains study author Christopher Gardner, director of nut...
Source: TIME: Health - February 20, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition healthytime onetime Source Type: news

Viral hormones have potential to cause diabetes in humans
According to a study inPNAS, scientists have identified four viruses that produce insulin-like peptides capable of stimulating human cells. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 20, 2018 Category: Endocrinology Source Type: news

Diabetes could be triggered by virus, scientists warn
Harvard University scientists found that four viruses contain insulin-like proteins. The new research suggests that these may trigger type 1 and type 2 diabetes by tricking the body. (Source: the Mail online | Health)
Source: the Mail online | Health - February 19, 2018 Category: Consumer Health News Source Type: news

Ketogenic Drinks Improve Glycemia and Insulin Sensitivity Ketogenic Drinks Improve Glycemia and Insulin Sensitivity
A small trial in healthy volunteers hints at a possible role for'keto drinks'in metabolic disorders.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 19, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Insulin goes viral
(Joslin Diabetes Center) Scientists at Joslin Diabetes Center have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 19, 2018 Category: Cancer & Oncology Source Type: news

How the insulin receptor works
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) Researchers from the Helmholtz Zentrum M ü nchen at the University Hospital Carl Gustav Carus of TU Dresden together with colleagues from Rockefeller University New York succeeded for the first time in the visualization of the insulin receptor activation. The results of this collaborative work have now been published in the 'Journal of Cell Biology'. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2018 Category: International Medicine & Public Health Source Type: news

High-dose Insulin Works for Beta-blocker, Calcium-channel Blocker Poisoning High-dose Insulin Works for Beta-blocker, Calcium-channel Blocker Poisoning
High-dose insulin is a feasible, effective treatment for beta-blocker and calcium-channel blocker poisoning, according to the 17-year experience of one poison center department.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 16, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Valeritas Presents Data Demonstrating V-Go & #194; & #174; Wearable Insulin Delivery Device ...
BRIDGEWATER, N.J., Feb. 15, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it presented positive findings from its MOTIV4CONTROL study as a poster at The 11th International Conference on Advanced Technologies&...This story is related to the following:Medical Devices (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - February 16, 2018 Category: Medical Devices Source Type: news

FDA issues warning for Roche ’ s Accu-Chek diabetes management app
The FDA today issued a Class 2 device recall for Roche‘s (OTC:RHHBY) Accu-Chek connected diabetes management app. The company first notified the regulatory agency of the software bug in June last year. Roche reported that certain iOS and Andriod versions of the app had a program error in the Bolus Advisor feature – a calculator that helps the user determine insulin doses based on data from a glucose meter. Get the full story at our sister site, Drug Delivery Business News. The post FDA issues warning for Roche’s Accu-Chek diabetes management app appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Patient Monitoring Pharmaceuticals Recalls Wall Street Beat Roche Source Type: news

FDA Okays Glooko Insulin Dosing System for Type 2 Diabetes FDA Okays Glooko Insulin Dosing System for Type 2 Diabetes
New app allows clinicians to personalize insulin dose titration for patients and reminds them to follow instructions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 16, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Tandem inks distribution deal in Scandinavia for insulin pumps
Tandem Diabetes Care (NSDQ:TNDM) has inked a distribution agreement with Rubin Medical to commercialize the medical device company’s t:slim X2 insulin pump, insulin cartridges and t:lock infusion sets in Sweden, Norway and Denmark. According to the terms of the deal, Rubin Medical is slated to perform all sales, marketing and customer training for Tandem’s devices. Get the full story at our sister site, Drug Delivery Business News. The post Tandem inks distribution deal in Scandinavia for insulin pumps appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat tandemdiabetes Source Type: news

Digital health news briefs for 2/15/2018
Insulin dose tool gains CE Mark.  DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro. The tool’s algorithms process data from a number of connected diabetes management devices to provide a personalized insulin dosing treatment plan. (Source: mobihealthnews)
Source: mobihealthnews - February 15, 2018 Category: Information Technology Source Type: news

Tandem Diabetes touts pivotal study of insulin pump with low glucose suspend feature
Tandem Diabetes Care (NSDQ:TNDM) touted data today from a pivotal study of its t:slim X2 insulin pump, which features a predictive low glucose suspend feature called Basal-IQ. The study showed that the system reduced time spent in hypoglycemia by 31% compared to just sensor-augmented pump therapy, according to Tandem. Get the full story at our sister site, Drug Delivery Business News. The post Tandem Diabetes touts pivotal study of insulin pump with low glucose suspend feature appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 15, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat tandemdiabetes Source Type: news

DreaMed Diabetes wins CE Mark for insulin therapy management platform
DreaMed Diabetes has won CE Mark clearance for its Advisor Pro decision-support platform, designed to help healthcare professionals manage insulin therapy for their Type I diabetes patients. The company’s cloud-based platform provides personalized insulin treatment plans by combining data from insulin pumps and continuous glucose monitors. Using machine learning techniques, the system analyzes all of the data it collects from connected devices to come up with an optimized insulin dosing treatment plan. Get the full story at our sister site, Drug Delivery Business News. The post DreaMed Diabetes wins CE Mark for ...
Source: Mass Device - February 15, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Regulatory/Compliance DreaMed Diabetes Glooko Source Type: news

Amish People Stay Healthy in Old Age. Here ’s Their Secret
Many people think of the Amish as living without. These devout communities, predominantly located in Pennsylvania, Ohio and Indiana, go without cars, TVs, computers, phones or even the electricity needed to run so much of 21st century gadgetry. But what researchers who have studied them have found is what the Amish have a surplus of: good health in late life. The average American life expectancy is currently just under 79 years. Back in 1900, it was only 47, but for early–20th century Amish it was already greater than 70. Over the decades, most Americans have caught up in overall life expectancy, but the Amish still ...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized amish communities healthytime Source Type: news

Sanofi touts real-world data for Toujeo insulin glargine injection
Sanofi (NYSE:SNY) touted data today from its 10,000-patient Lightning study, which evaluated electronic medical records of adults with Type II diabetes to study its long-acting insulin glargine injection, Toujeo. The company found that Toujeo significantly lowered patients’ risk of experiencing severe low blood sugar compared to other long-acting insulin, like its own Lantus product. Get the full story at our sister site, Drug Delivery Business News. The post Sanofi touts real-world data for Toujeo insulin glargine injection appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 14, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Sanofi-Aventis Source Type: news

Glooko receives FDA clearance for mobile insulin titration tool
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA. (Source: mobihealthnews)
Source: mobihealthnews - February 14, 2018 Category: Information Technology Source Type: news

Glooko wins FDA nod for mobile insulin dosing system
The FDA has approved Glooko‘s mobile insulin dosing system, which is designed to titrate long-acting insulin for people with Type II diabetes. The company’s system accesses blood glucose data directly from the user’s glucose meter so that the user doesn’t have to manually enter their fasting glucose values. Then, it analyzes those levels to recommend insulin dose adjustments based on a healthcare provider’s treatment plan and published clinical guidelines. Get the full story at our sister site, Drug Delivery Business News. The post Glooko wins FDA nod for mobile insulin dosing system appe...
Source: Mass Device - February 14, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Glooko Source Type: news

Health Tip: Sleep's Effects on Diabetes
-- Lack of sleep is an often overlooked risk factor for type 2 diabetes, the National Sleep Foundation says. Chronic sleep deprivation leads to less insulin production and increased production of stress hormones, the foundation says. Over time, too... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2018 Category: General Medicine Source Type: news

Going vegan can prevent overweight people from diabetes
Following a plant-based diet can boost insulin sensitivity in fat people, found researchers at the Physicians Committee for Responsible Medicine in Washington DC. (Source: the Mail online | Health)
Source: the Mail online | Health - February 13, 2018 Category: Consumer Health News Source Type: news

Insulet ’s closed-loop insulin delivery algorithm succeeds in feasibility study
The algorithm used in Insulet‘s (NSDQ:PODD) closed-loop insulin delivery system performed well in a 58-patient safety and feasibility study, according to a study published today in Diabetes Technology & Therapeutics. Insulet’s device, which is still in development, combines an insulin dosing algorithm, the OmniPod insulin patch pump and Dexcom‘s (NSDQ:DXCM) continuous glucose monitor into one system that automates insulin delivery based on the user’s blood sugar levels. Get the full story at our sister site, Drug Delivery Business News. The post Insulet’s closed-lo...
Source: Mass Device - February 13, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Research & Development Wall Street Beat Dexcom Insulet Source Type: news

Diabetes clinic taps DarioHealth for blood glucose monitoring tech
DarioHealth (NSDQ:DRIO) has partnered with the Diabetes and Endocrinology Consultants of Pennsylvania to bring its blood glucose monitoring system to the 5,000-patient facility. The company’s blood glucose monitor, which syncs with Dario’s diabetes management app, connects via a headphone jack to a mobile device, helping diabetes patients monitor their blood glucose throughout the day. The app also records carbohydrate intake, insulin use and physical activity. Get the full story at our sister site, Drug Delivery Business News. The post Diabetes clinic taps DarioHealth for blood glucose monitorin...
Source: Mass Device - February 13, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Hospital Care Patient Monitoring DarioHealth Corp Source Type: news

Research Fellow – Full-time (Fixed Term) at the Institute of Metabolism and Systems Research (IMSR), University of Birmingham
Location:Department of Physiology, Development and NeuroscienceSalary: £29,799 -£38,832Closing Date: 8 March 2018Post Duration: 36 monthsUniversity of Birmingham are seeking a talented and motivated postdoctoral fellow to join Prof. David Hodson’s research group atthe Institute of Metabolism and Systems Research (IMSR), University of Birmingham. The project, funded for 36 months by a Diabetes UK Research Grant, seeks to understand how stress hormones (termed glucocorticoids) influence beta cell function and insulin release, and how this may interact with obesity To do this, w...
Source: Society for Endocrinology - February 13, 2018 Category: Endocrinology Source Type: news

Here ’s Why Eating More Slowly May Help You Lose Weight
People looking to lose weight might try all kinds of ways to eat fewer calories. Now, a study in BMJ Open sheds some light onto which of those strategies actually work: Based on data from nearly 60,000 people, three behaviors—eating slowly, cutting out after-dinner snacks and not eating within two hours of going to bed—were linked to lower obesity rates and smaller waistlines. The study looked specifically at people in Japan with type 2 diabetes who had one to three health check-ups between 2008 and 2013. During those appointments, people were asked about their eating and sleeping habits, including how fast the...
Source: TIME: Health - February 12, 2018 Category: Consumer Health News Authors: Amanda MacMillan Tags: Uncategorized healthytime onetime Weight loss Source Type: news

Why Pharma Needs to Understand Population Health
It ’s no secret that healthcare is under growing pressure to reduce the cost of care while improving quality. Linkage of payment for healthcare to the cost and quality delivered – the idea behind value-based payment frameworks – is the driving force behind today’s rapidly changing healthcare la ndscape.Such linkage will likely be achieved using a population health model, where a provider contracts to deliver designated services to specific quality targets at an agreed-upon ‘all-in’ price. The arrangement makes the contracting provider financially accountable for cost over-runs and qualit...
Source: EyeForPharma - February 12, 2018 Category: Pharmaceuticals Authors: Rita Numerof Source Type: news

Insulet settles investor suit for $20m
Insulet (NSDQ:PODD) plans to fork over $19.5 million to settle a class action lawsuit brought by the Arkansas Teacher Retirement System, the City of Bristol Pension Fund and the City of Omaha Police and Fire Retirement System, according to court documents. The lawsuit alleged that Insulet misrepresented the success of its OmniPod Eros roll-out in 2013, which eventually caused shares in the company to plummet. The insulin-delivery device had a number of manufacturing problems when it was launched five years ago, which the plaintiffs argued were kept hidden from investors. Get the full story at our sister site...
Source: Mass Device - February 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Legal News Pharmaceuticals Wall Street Beat Insulet Source Type: news

Could beer have beneficial health effects?
According to a study, published inScientific Reports, a key ingredient of beer, (xanthohumal) may reduce insulin and leptin resistance.Daily Mail (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 12, 2018 Category: Endocrinology Source Type: news

Experts Questioning Study on Insulin Quality
Title: Experts Questioning Study on Insulin QualityCategory: Health NewsCreated: 2/9/2018 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - February 12, 2018 Category: Endocrinology Source Type: news

New study shows vegan diet improves diabetes markers in overweight adults
(Physicians Committee for Responsible Medicine) A plant-based diet improves beta-cell function and insulin sensitivity in overweight adults with no history of diabetes, according to a new study published in Nutrients by researchers from the Physicians Committee for Responsible Medicine.Measuring the function of beta cells, which store and release insulin, can help assess future type 2 diabetes risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Tiny drug-delivering capsules could sustain transplanted insulin-producing cells
(University of Illinois at Urbana-Champaign) A drug-carrying microsphere within a cell-bearing microcapsule could be the key to transplanting insulin-secreting pig pancreas cells into human patients whose own cells have been destroyed by type I diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

EndoBreak: Insulin Quality in Question; Apple Watch Knows Diabetes
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 9, 2018 Category: Cardiology Source Type: news

Peptide shows potential in becoming next diabetes drug
Catestatin treatment significantly improves glucose and insulin sensitivity in mice, a study inDiabetes reports. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 9, 2018 Category: Endocrinology Source Type: news

Insulin study worries some with diabetes
About 6 million Americans inject insulin daily to control diabetes, and a researcher is raising questions about quality control (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 8, 2018 Category: Consumer Health News Source Type: news

What Would Lady Gaga & #039;s Insulin Pump Look Like (if She Needed One)?
Just to be clear, Lady Gaga does not, to the best of our knowledge, have diabetes. But what if she did? What would her insulin pump look like, if a medical device developer personalized the life-saving gadget based on everything the American singer-songwriter represents? "It would be empowering. Lady Gaga talks about accepting yourself, you know, 'going this way'," Eric Larson, a mechanical engineer with over thirty years experience in plastics design, told MD&M West attendees. "Most people make insulin pumps to hide them. We have eyeglasses, but nobody's ashamed to have bad vision, right? I even have 15...
Source: MDDI - February 8, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M West (Anaheim) Design Source Type: news